Aims and Scope

Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research.

Editorial Board

For information about the Annals of the Rheumatic Diseases Editor-in-Chief Prof Josef Smolen and his editorial team, please refer to the Editorial Board page.


ARD is co-owned by the European League Against Rheumatism (EULAR) and BMJ.

Journal Information

Publication Model Subscription; with hybrid open access option
Frequency Monthly
Launch date 1939
Digital Archive LOCKSS
Indexed by Web of Science Core Collection: Science Citation Index, Science Citation Index Expanded; BIOSIS Previews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medica), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Impact Factor 16.102, rank 2/32 Rheumatology (2019)
CiteScore 25.9, rank 1/56 Rheumatology (2019)
Peer Review Model Single blind; the names of reviewers are hidden from the author
Print ISSN 0003-4967
Online ISSN 1468-2060

Journal Statistics (2019)

Acceptance Rate 24%
Time from submission to first decision 10 days
Time from acceptance to online publication 13 days

Contact Information

For all contact information please refer to the Contact Us page.

For Authors

Please refer to the Instructions for Authors.


To advertise

Rights and Permissions


ARD is the official journal of EULAR – the European League Against Rheumatism and all (scientific) delegates to the annual EULAR congress receive a complimentary 12 month subscription to the journal.
COPE logo

BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.


The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.